Cargando…
Efficacy of an HSV-1 Neuro-Attenuated Vaccine in Mice Is Reduced by Preventing Viral DNA Replication
We previously isolated an HSV-1 mutant, KOS-NA, that contains two non-synonymous mutations in UL39. One of the mutations, resulting in an R950H amino acid substitution in ICP6, renders KOS-NA severely neuro-attenuated and significantly reduces HSV-1 latency. Vaccination of mice with KOS-NA prior to...
Autores principales: | Wang, Hong, Davido, David J., Mostafa, Heba H., Morrison, Lynda A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144315/ https://www.ncbi.nlm.nih.gov/pubmed/35632611 http://dx.doi.org/10.3390/v14050869 |
Ejemplares similares
-
HSV-1 ICP0: An E3 Ubiquitin Ligase That Counteracts Host Intrinsic and Innate Immunity
por: Lanfranca, Mirna Perusina, et al.
Publicado: (2014) -
HSV-1 DNA Replication—Coordinated Regulation by Viral and Cellular Factors
por: Packard, Jessica E., et al.
Publicado: (2021) -
ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against HSV-2 Infection in Mice
por: Korom, Maria, et al.
Publicado: (2023) -
Immunogenicity, Protective Efficacy, and Non-Replicative Status of the HSV-2 Vaccine Candidate HSV529 in Mice and Guinea Pigs
por: Bernard, Marie-Clotilde, et al.
Publicado: (2015) -
ICP4-induced miR-101 attenuates HSV-1 replication
por: Wang, Xiangling, et al.
Publicado: (2016)